RxDoctor Payments Data

Sean Ryan, MD

Vascular Surgery · Lewes, DENPI 1891991402

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (46.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Angiodynamics, Inc. at 59.4% of the total.

$46,755in general payments, 2019–2025

Across 313 payments — averaging $149.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$28K
  • Medtronic$6K
  • Cardiovascular Systems Inc.$4K
  • Silk Road Medical, Inc.$2K
  • W. L. Gore & Associates, Inc.$2K
  • Cook Medical LLC$1K
  • plus $4K from 26 others

What the payments were for

  • Travel & lodging$6,68114%
  • Food & beverage$12,53027%
  • Education$5,60012%
  • Other$21,94447%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular surgery providers in Delawareto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$483,197
Medicare patients
1,372
Services billed
5,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban35$27,569
ClopidogrelClopidogrel Bisulfate103$1,475
Cilostazol26$417
Oxycodone Hcl11$74

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lewes

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →